• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

cathworks

Cantel Medical taps ex-Cardinal Health COO Fotiades for CEO | Personnel Moves, March 5, 2019

March 5, 2019 By Brad Perriello

 Cantel Medical taps ex-Cardinal Health vet for CEO Cantel Medical (NYSE:CMD) said today that it named former Cardinal Health (NYSE:CAH) COO George Fotiades to be its new president & CEO, replacing Jorgen Hansen effective immediately. Fotiades will retain his seat on Cantel’s board, the Little Falls, N.J.-based company said. “On behalf of the board, I am very […]

Filed Under: Blog Tagged With: Activ Surgical, BioDirection, Cantel Medical Corp., cathworks, CHF Solutions Inc., Globus Medical, Misonix, Personnel Moves, sciton, Sensus Healthcare LLC, Zynex

Owens & Minor taps former Thermo Fisher CCO Pesicka as prez, CEO | Personnel Moves – February 27, 2019

February 27, 2019 By Fink Densford

Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]

Filed Under: Business/Financial News, Featured Tagged With: AliveCor, Anaconda Biomed, cathworks, cirtronics, Deerfield Management, IsoRay, Magnolia Medical Technologies, mcginleyorthopedics, Owens and Minor, SurModics Inc., Thermo Fisher Scientific, Xtant Medical, Zimmer Biomet

CathWorks raises $30m in Series C

February 5, 2019 By Fink Densford

CathWorks said today that it closed a $30 million Series C round of financing to support its FFRangio non-invasive fractional flow reserve tech. The FFRangio system is designed to provide objective FFR guidance for optimizing percutaneous coronary intervention therapy decisions, the Israel-based company said. FFRangio is derived from routine X-rays during diagnostic angiogram procedures and is […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Wall Street Beat Tagged With: cathworks

Former Rotation Medical CEO Shadan joins Miach Ortho | Personnel Moves – January 3, 2019

January 3, 2019 By Fink Densford

Early stage medtech firm Miach Orthopaedics said today that it named former Rotation Medical CEO and medtech vet Martha Shadan as its new prez and chief executive officer. Shadan has held numerous leadership positions at medtech firms, including Zimmer Biomet (NYSE:ZBH), Covidien, Bristol Myers Squibb and Merck, Westborough, Mass.-based Miach said. Prior to joining Miach, Shadan […]

Filed Under: Business/Financial News, Featured Tagged With: cathworks, Endotronix Inc., iCad Inc., lightmed, Miach Orthopaedics, Nephros, Nobilis Health, Nuvasive, Obalon Therapeutics, Personnel Moves, Repro Med Systems, rotationmedical, Tela Bio

CathWorks wins FDA 510(k) for FFRangio

December 21, 2018 By Fink Densford

Non-invasive fractional flow reserve tech developer CathWorks said yesterday that it won FDA 510(k) clearance for its FFRangio non-invasive fractional flow reserve analysis technology. The Israel-based company said that approval came based off of results from the FAST-FFR blinded comparative study study which showed that its FFRangio system was accurate when compared to invasive FFR. “The FDA […]

Filed Under: 510(k), Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: cathworks

TCT 2018: Abbott touts low rates of stroke, death in 1-year Portico TAVR study

September 25, 2018 By Fink Densford

Abbott (NYSE:ABT) today released one-year results from a study exploring the use of its Portico transcatheter aortic valve replacement system in patients with symptomatic, severe aortic stenosis, touting low rates of stroke, death and leaks between the valve and native heart tissue. Results from the Portico 1 study were presented during a late-breaking session at the Transcatheter […]

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Replacement Heart Valves Tagged With: Abbott, advancebifurcationsystems, cathworks, InfraReDx Inc.

CathWorks touts reimbursement win for non-invasive FFR tech

July 12, 2018 By Fink Densford

Non-invasive fractional flow reserve tech developer CathWorks said yesterday it won a new CPT code covering its 3D FFRangio non-invasive fractional flow reserve analysis technology. The Israel-based company’s 3D FFRangio technology is now reimbursable when used for the real-time review of possible atherosclerotic stenosis during coronary angiography interventions. The FFRangio tech is designed as a non-invasive FFR […]

Filed Under: Business/Financial News, Diagnostics, Vascular Tagged With: cathworks

Sterilis taps ex-Nanosphere CEO McGarrity as chief exec | Personnel Moves – November 1, 2017

November 1, 2017 By Fink Densford

Medical sterilization company Sterilis said yesterday it tapped former Nanosphere (NSDQ:NSPH) chief exec Michael McGarrity as its new CEO. McGarrity held the CEO position at Nanosphere from February 2013 to last June when he oversaw the company’s $76.9 million acquisition by Luminex (NSDQ:LMNX). Prior to his time as head of Nanosphere, McGarrity held positions in sales, marketing […]

Filed Under: Business/Financial News Tagged With: AdvaMed, Alphatec, Baylis Medical, Boston Scientific, cathworks, ev3 Inc., Home Diagnostics Inc., Integra LifeSciences, Invuity, linkspine, Luminex, Medicrea, Medizone, Nanosphere, Second Sight, sterilis, Stryker, Varian Medical Systems, Vertos Medical

CathWorks closes $16m Series B to support non-invasive FFR platform

October 3, 2017 By Fink Densford

Non-invasive fractional flow reserve tech developer CathWorks said yesterday it closed a $15.8 million Series B round of financing to support its real-time digital platform designed to determine FFR in cath labs. The round was led by Quark Venture and Triventures and joined by Planven Investments, Pontifax, Corundum Open Innovation, BioStar Ventures and an unnamed […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Catheters Tagged With: cathworks

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS